Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its access have become key concerns for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant obstacle to many.